Company · CIK 1810182
ALX ONCOLOGY HOLDINGS INC
| CIK | 1810182 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ALXO (Nasdaq) |
| First annual or quarterly report | 2020-08-27 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285620 | 2025-03-06 | 2026-01-30 | 3 | |
| 333-263863 | 2022-03-25 | 2023-10-06 | 5 | |
| 333-274314 | 2023-09-01 | 2023-09-08 | 2 | |
| 333-258812 | 2021-08-13 | 2022-05-31 | 3 | |
| 333-251171 | 2020-12-07 | 2020-12-11 | 3 | |
| 333-239490 | 2020-06-26 | 2020-07-17 | 4 |
Filings
22| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-30 | 424B5Shelf takedown | 333-285620 | 0001193125-26-031754 |
| 2025-04-24 | EFFECTDeclared effective | 333-285620 | 9999999995-25-001231 |
| 2025-03-06 | S-3Shelf registered | 333-285620 | 0001193125-25-048564 |
| 2023-10-06 | 424B5Shelf takedown | 333-263863 | 0001193125-23-251913 |
| 2023-10-04 | 424B5Shelf takedown | 333-263863 | 0001193125-23-250821 |
| 2023-09-08 | EFFECTDeclared effective | 333-274314 | 9999999995-23-002617 |
| 2023-09-01 | S-3Shelf registered | 333-274314 | 0001193125-23-227645 |
| 2023-08-25 | 424B5Shelf takedown | 333-263863 | 0001193125-23-221567 |
| 2022-05-31 | EFFECTDeclared effective | 333-258812 | 9999999995-22-001634 |
| 2022-05-25 | EFFECTDeclared effective | 333-263863 | 9999999995-22-001588 |
| 2022-03-25 | S-3Shelf registered | 333-263863 | 0001193125-22-085234 |
| 2021-12-17 | 424B5Shelf takedown | 333-258812 | 0001193125-21-361264 |
| 2021-08-13 | S-3ASRShelf registered | 333-258812 | 0001193125-21-246134 |
| 2020-12-11 | 424B4Final prospectus | 333-251171 | 0001193125-20-315060 |
| 2020-12-09 | EFFECTDeclared effective | 333-251171 | 9999999995-20-003466 |
| 2020-12-07 | S-1Registration filed | 333-251171 | 0001193125-20-311731 |
| 2020-11-24 | DRSDraft made public | 377-03819 | 0000950123-20-012354 |
| 2020-07-17 | 424B4Final prospectus | 333-239490 | 0001193125-20-194755 |
| 2020-07-16 | EFFECTDeclared effective | 333-239490 | 9999999995-20-001829 |
| 2020-07-13 | S-1/AAmendment | 333-239490 | 0001193125-20-191500 |
| 2020-06-26 | S-1Registration filed | 333-239490 | 0001193125-20-181021 |
| 2020-05-05 | DRSDraft made public | 377-03152 | 0000950123-20-003925 |